News Focus
News Focus
Post# of 257382
Next 10
Followers 91
Posts 20364
Boards Moderated 3
Alias Born 11/05/2005

Re: ronpopeil post# 242685

Friday, 06/03/2022 7:51:07 AM

Friday, June 03, 2022 7:51:07 AM

Post# of 257382
Turning Point Therapeutics (TPTX) – The biopharmaceutical company’s shares more than doubled in premarket trading after agreeing to be acquired by Bristol Myers Squibb (BMY) for $76 per share in cash, or $4.1 billion. Turning Point specializes in cancer treatments. UP $40 premarket!

Bull-markets are born on pessimism, grow on skepticism, mature on optimism and die on euphoria .. Sir John Templeton
Make your Life a Mission .... NOT an Intermission. † §|PL1|§

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today